Scopus
YÖKSİS DOI Eşleşti
SJR Q1
Investigation of in vitro antimicrobial and cytotoxic effects of gold nanoparticles capped with meropenem and imipenem
Nanomedicine · Ekim 2023
YÖKSİS Kayıtları
Investigation of in vitro antimicrobial and cytotoxic effects of gold nanoparticles capped with meropenem and imipenem
Nanomedicine · 2023 SCI-Expanded
Prof. Dr. İDRİS SARGIN →
Investigation of in vitro antimicrobial and cytotoxic effects of gold nanoparticles capped with meropenem and imipenem
Nanomedicine · 2023 SCI
Prof. Dr. SERDAR KARAKURT →
Investigation of in vitro antimicrobial and cytotoxic effects of gold nanoparticles capped with meropenem and imipenem
Nanomedicine · 2023 SCI-Expanded
Prof. Dr. GÜLŞİN ARSLAN →
Investigation of in vitro antimicrobial and
cytotoxic effects of gold nanoparticles
capped with meropenem and imipenem
Nanomedicine · 2023 SCI-Expanded
Prof. Dr. UĞUR ARSLAN →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Investigation of in vitro antimicrobial and cytotoxic effects of gold nanoparticles capped with meropenem and imipenem
2023 ISSN: 1743-5889 SCI-Expanded Q1
Prof. Dr. İDRİS SARGIN →
Investigation of in vitro antimicrobial and cytotoxic effects of gold nanoparticles capped with meropenem and imipenem
2023 ISSN: 1743-5889 SCI-Expanded Q1
Prof. Dr. GÜLŞİN ARSLAN →
Investigation of in vitro antimicrobial and
cytotoxic effects of gold nanoparticles
capped with meropenem and imipenem
2023 ISSN: 1743-5889 SCI-Expanded Q1
Prof. Dr. UĞUR ARSLAN →
Investigation of in vitro antimicrobial and cytotoxic effects of gold nanoparticles capped with meropenem and imipenem
2023 ISSN: 1743-5889 SCI
Prof. Dr. SERDAR KARAKURT →
Makale Bilgileri
Dergi
Nanomedicine
ISSN17435889
Yayın TarihiEkim 2023
Cilt / Sayfa18 · 1719-1731
Scopus ID2-s2.0-85178497723
Scimago Dergi (ISSN Eşleşmesi)
Nanomedicine
Q1
SJR Skoru0,681
H-Index148
YayıncıTaylor and Francis Ltd.
ÜlkeUnited Kingdom
Development (Q1)
Bioengineering (Q2)
Biomedical Engineering (Q2)
Materials Science (miscellaneous) (Q2)
Medicine (miscellaneous) (Q2)
Nanoscience and Nanotechnology (Q2)
Metrikler
4
Atıf